Psoriasis and cardiovascular diseases

Acta Cardiologica

Volumn 65, Issue 3, 2010, Pages 337-340

  Vizzardi, Enrico ^a   Raddino, Riccardo ^a   Teli, Melissa ^a   Gorga, Elio ^a   Brambilla, Giulio ^a   Dei Cas, Livio ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Cardiovascular disease; Psoriasis

Indexed keywords

DISEASE ASSOCIATION; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; PSORIASIS; REVIEW; RISK FACTOR; VALVULAR HEART DISEASE;

CARDIOVASCULAR DISEASES; HUMANS; PSORIASIS; RISK FACTORS;

EID: 77955803553     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.65.3.2050351     Document Type: Review

References (27)

1. Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005; 141: 1537-41.
2. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004; 9: 136-9.
3. Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, Stern RS, Feldman SR, Rolstad T. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005; 53: 573.
4. Shbeeb M, Uramoto KM, Gibson LE, O'Fallon WM, Gabriel SE. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol 2000; 27: 1247-50.
5. Krueger JG, Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005; 64 (suppl 2): ii30-ii36. (Pubitemid 40288517)
6. Schon MP, Boehncke WH. Psoriasis. N Engl J Med 2005; 352: 1899-1912.
7. Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F. The inflammatory response in mild and in severe psoriasis. Br J Dermatol 2004; 150: 917-28.
8. Chodorowska G, Wojnowska D, Juszkiewicz-Borowiec M. C-reactive protein and alpha2-macroglobulin plasma activity in medium-severe and severe psoriasis. J Eur Acad Dermatol Venereol 2004; 18: 180-3. (Pubitemid 38379896)
9. Vanizor Kural B, Orem A, Cimsit G, Uydu HA, Yandi YE, Alver A. Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients. Clin Chim Acta 2003; 332: 23-30.
10. Lindegård B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica 1986, 172: 298-304. (Pubitemid 16014779)
11. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32: 982-6.
12. Marino MG, Carboni I, De Felice C, Maurici M, Maccari F, Franco E. Risk factors for psoriasis: a retrospective study on 501 outpatients clinical records. Ann Ig 2004, 16: 753-8.
13. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829-35. (Pubitemid 44556851)
14. Mehta NN, Azfar RS, Shin DB, Neiman AL, Troxel AB, Gelfand JM. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J 2009 Dec 27 [Epub ahead of print].
15. Kaye JA, Li L, Jick SS. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 2008; 159: 895-902.
16. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735-41. (Pubitemid 44547793)
17. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985; 13: 450-6. (Pubitemid 15016489)
18. Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005; 64 (suppl 2): ii18-ii23.
19. Xiao J, Chen LH, Tu YT, Deng XH, Tao J. Prevalence of myocardial infarction in patients with psoriasis in central China. J Eur Acad Dermatol Venereol 2009; 23: 1311-5.
20. Liu T, Li G. Is atrial fibrillation an inflammatory disease? Med Hypotheses 2005; 64: 1237-8.
21. Liu T, Li L, Korantzopoulos P, Goudevenos JA, Li G. Meta-analysis of association between C-reactive protein and immediate success of electrical cardioversion in persistent atrial fibrillation. Am J Cardiol 2008; 101: 1749-52.
22. Liu T, Li G, Li L, Korantzopoulos P. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol 2007; 49: 1642-8.
23. Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007, 115: 135-43. (Pubitemid 46136515)
24. Markuszeski L, Bissinger A, Janusz I, Narbutt J, Jedrzejowska AS, Zalewska A. Heart rate and arrhythmia in patients with psoriasis vulgaris. Arch Med Res 2007; 38: 64-9.
25. Gunes Y, Tuncer M, Calka O, Guntekin U, Akdeniz N, Simsek H, Ozdemir IY. Increased frequency of pulmonary hypertension in psoriasis patients. Arch Dermatol Res 2008; 300: 435-40.
26. Nijsten T, Wakkee M. Complexity of the association between psoriasis and comorbidities. J Invest Dermatol 2009; 129: 1601-3.
27. Schmitt J, Ford DE. Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample. J Eur Acad Dermatol Venereol 2009 Dec 10 [Epub ahead of print].